Gao J, Yang T, Song B, Ma X, Ma Y, Lin X, et al. Abnormal tryptophan catabolism in diabetes mellitus and its complications: Opportunities and challenges. Biomed Pharmacother. 2023;166: 115395.
Semertzidou A, Grout-Smith H, Kalliala I, Garg A, Terzidou V, Marchesi J, et al. Diabetes and anti-diabetic interventions and the risk of gynaecological and obstetric morbidity: an umbrella review of the literature. BMC Med. 2023;21:152.
Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, Dalton BE, Duprey J, Cruz JA, Hagins H, Lindstedt PA. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203–34.
Zhang S, Tong X, Wang L, Zhang T, Huang J, Wang D, et al. Clinical characteristics and prognostic analysis of patients with pulmonary tuberculosis and type 2 diabetes comorbidity in china: a retrospective analysis. Front Public Health. 2021;9: 710981.
Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9:737–46.
WHO. Global tuberculosis report 2022.
Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393:1642–56.
Zhao H, Shi L, Wang X, Yu X, Wang D. Sp1 transcription factor represses transcription of phosphatase and tensin homolog to aggravate lung injury in mice with type 2 diabetes mellitus-pulmonary tuberculosis. Bioengineered. 2022;13:9928–44.
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5: e152.
Yang H, Song J, Li A, Lv L, Sun X, Mao Y, et al. Genetically predicted levels of folate, vitamin B(12), and risk of autoimmune diseases: a Mendelian randomization study. Front Immunol. 2023;14:1139799.
Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, et al. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol. 2008;167:1486–94.
Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis. 2012;54:818–25.
Ling C, Bacos K, RöNN T. Epigenetics of type 2 diabetes mellitus and weight change – a tool for precision medicine? Nat Rev Endocrinol. 2022;18:433–48.
Meyer CG, Thye T. Host genetic studies in adult pulmonary tuberculosis. Semin Immunol. 2014;26:445–53.
Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50:1505–13.
Liu H, Hu Y, Zhang Y, Zhang H, Gao S, Wang L, et al. Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer’s disease GWAS and self-report proxy phenotype GWAX. Alzheimers Res Ther. 2022;14:17.
Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018. https://doi.org/10.1136/bmj.k601.
Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925–6.
Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, Vanderweele TJ, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375: n2233.
Elsworth B, Lyon M, Alexander T, Liu Y, Matthews P, Hallett J, et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv. 2020;35:99.
Spracklen CN, Horikoshi M, Kim YJ, Lin K, Bragg F, Moon S, et al. Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature. 2020;582:240–5.
Sollis E, Mosaku A, Abid A, Buniello A, Cerezo M, Gil L, et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 2023;51:D977–85.
Ishigaki K, Akiyama M, Kanai M, Takahashi A, Kawakami E, Sugishita H, et al. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat Genet. 2020;52:669–79.
Harrison R, Munafò MR, Smith GDavey, Wootton RE. Examining the effect of smoking on suicidal ideation and attempts: triangulation of epidemiological approaches. Br J Psychiatry. 2020;217:701–7.
Cohen JF, Chalumeau M, Cohen R, Korevaar DA, Khoshnood B, Bossuyt PM. Cochran’s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy. J Clin Epidemiol. 2015;68:299–306.
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25.
Wu F, Huang Y, Hu J, Shao Z. Mendelian randomization study of inflammatory bowel disease and bone mineral density. BMC Med. 2020;18:312.
Webber T, Ronacher K, Conradie-Smit M, Kleynhans L. Interplay between the immune and endocrine systems in the lung: implications for TB susceptibility. Front Immunol. 2022;13: 829355.
Hernández-Bustamante I, Santander-Plantamura Y, Mata-Espinosa D, Reyes-Chaparro A, Bini EI, Torre-Villalvazo I, et al. Structural homology between 11 beta-hydroxysteroid dehydrogenase and Mycobacterium tuberculosis Inh-A enzyme: Dehydroepiandrosterone as a potential co-adjuvant treatment in diabetes-tuberculosis comorbidity. Front Endocrinol. 2022;13:1055430.
Turner DP, Houle TT. Observational study designs. Headache. 2019;59:981–7.
Zenil-Vega M, Cerón E, López-bello G, Moreno J, Juárez-Cruz E, Castillejos-López M, et al. An association between glycine and insulin levels is observed in patients with pulmonary tuberculosis and type 2 diabetes. Clin Nutr. 2020;39:3019–23.
Li X, Zhong Z, Liu Y, Gong G, Zhang Y, Wang Y, et al. Dietary pattern characterized by a balanced diet rich in high-quality protein intake is associated with mild initial clinical manifestations in tuberculosis. Front Nutr. 2022;9: 912703.
Odone A, Houben RM, White RG, LöNNROTH K. The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol. 2014;2:754–64.
Oglesby W, Kara AM, Granados H, Cervantes JL. Metformin in tuberculosis: beyond control of hyperglycemia. Infection. 2019;47:697–702.
Add Comment